MYX mayne pharma group limited

News: MYX Mayne Pharma Expects Q4 To Be Stronger Driven By Rebound In Generic Products, page-2

  1. 389 Posts.
    lightbulb Created with Sketch. 36
    Does anyone have an opinion on or experience with Mayne's track record on reliability of their forward looking statements? If they say generic sales will improve, should we take it at face value and rely on it?
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$5.00
Change
-0.080(1.57%)
Mkt cap ! $406.2M
Open High Low Value Volume
$5.08 $5.10 $4.95 $1.426M 285.1K

Buyers (Bids)

No. Vol. Price($)
1 50 $5.00
 

Sellers (Offers)

Price($) Vol. No.
$5.02 259 1
View Market Depth
Last trade - 16.10pm 30/06/2025 (20 minute delay) ?
MYX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.